Prevalence of predisposing conditions for AIFR
| Predisposing Condition | Prevalence in AIFR Group | Prevalence in Control Group |
|---|---|---|
| Acute myelogenous leukemia | 42.9% (18/42) | 38.1% (16/42) |
| Diabetes | 28.6% (12/42) | 9.5% (4/42) |
| Other leukemia (non-AML) | 19.0% (8/42) | 21.4% (9/42) |
| Multiple myeloma | 7.1% (3/42) | 7.1% (3/42) |
| Solid organ malignancy | 7.1% (3/42) | 0% (0/42) |
| Solid organ transplant | 4.8% (2/42) | 9.5% (4/42) |
| Myelodysplastic syndrome | 2.4% (1/42) | 7.1% (3/42) |
| Non-Hodgkin lymphoma | 2.4% (1/42) | 11.9% (5/42) |
| None | 2.4% (1/42) | 0% (0/42) |
Note:—AML indicates acute myelogenous leukemia.